Lupus Drug Is Approved Despite Previous Clinical Trial Setback

被引：0

|

作者：

Kuehn, Bridget M.

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2021年 / 326卷 / 11期

关键词：

D O I：

10.1001/jama.2021.15588

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1000 / 1000

页数：1

相关论文

共 50 条

[1] Epigenome drug approved after setback
不详
[J]. NATURE BIOTECHNOLOGY, 2015, 33 (05) : 437 - 437
[2] Epigenome drug approved after setback
[J]. Nature Biotechnology, 2015, 33 (5) : 437 - 437
[3] Biotechnology - British Biotech hopeful despite drug setback
不详
[J]. CHEMISTRY & INDUSTRY, 1999, (05) : 167 - 167
[4] Alzheimer's drug approved despite murky results
Servick, Kelly
[J]. SCIENCE, 2021, 372 (6547) : 1141 - 1141
[5] First Lupus Drug Approved In 50 years
不详
[J]. SCIENCE, 2011, 331 (6023) : 1370 - 1370
[6] SYNERGEN STOCK PLUNGES AFTER DRUG TRIAL SETBACK
THAYER, A
[J]. CHEMICAL & ENGINEERING NEWS, 1993, 71 (09) : 7 - 7
[7] Surprise setback for lung fibrosis drug highlights trial challenges
不详
[J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (07) : 506 - 506
[8] Surprise setback for lung fibrosis drug highlights trial challenges
[J]. Nature Reviews Drug Discovery, 2010, 9 : 506 - 506
[9] First new lupus drug approved in half-century
Thompson, Cheryl A.
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (08) : 646 - 646
[10] A review of clinical trial designs of typical orphan drugs approved by the Food and Drug Administration.
Haffner, M
Bona, J
Centeno-Deshields, D
Nguyen, T
Ott, C
Whitley, J
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1089 - 1089

← 1 2 3 4 5 →